Please Wait.....
Report
Australia Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-07-01 I 75 Pages I Mordor Intelligence
Australia Diabetes Devices Market Analysis
The Australia diabetes devices market is valued at USD 721.44 million in 2025 and is forecast to reach USD 814.65 million by 2030, expanding at a 2.46% CAGR. The Australia diabetes devices market size reflects a mature reimbursement environment, strong clinician acceptance of real-time glucose data, and steady technological upgrades that keep replacement cycles active. Wider National Diabetes Services Scheme (NDSS) subsidies for continuous glucose monitoring (CGM), the shift toward automated insulin delivery, and rising type 2 diabetes prevalence are underpinning demand. Integrated digital health infrastructure-especially universal electronic health records-reduces onboarding barriers for new devices and promotes data-driven care pathways. Global manufacturers are intensifying local partnerships to marry device ecosystems with the My Health Record platform, while start-ups concentrate on pain-free diagnostics aimed at underserved groups. Competitive momentum now centers on linking glucose data to broader cardiometabolic platforms, a move likely to reshape procurement criteria over the next five years.
Australia Diabetes Devices Market Trends and Insights
Expansion of CGM reimbursement via NDSS & private health funds
National reimbursement initiatives have transformed the Australia diabetes devices market by removing upfront cost barriers for real-time CGM. The NDSS CGM Initiative, which subsidises CGM for every person with type 1 diabetes, lifted utilisation from 5% to as high as 79% among eligible users . Insurers have complemented this policy, funding sensors for high-risk pregnancies and paediatric cohorts. Evidence from cost-utility studies shows an incremental cost-effectiveness ratio of AUD 39,518 per quality-adjusted life-year versus self-funded use . Heightened public coverage has also stimulated manufacturer competition, prompting quicker rollouts of next-generation sensors with longer wear time and factory calibration.
Escalating diabetes prevalence driving device demand
Diagnosed diabetes cases reached 1.3 million in 2025, with an additional 500,000 people undiagnosed, underscoring unmet monitoring needs. Type 2 diabetes accounts for seven in ten cases and is rising fastest in lower-income and Indigenous populations. The Australia diabetes devices market benefits directly, as primary-care guidelines encourage earlier CGM initiation for complex type 2 profiles. Advocacy groups are lobbying to extend NDSS subsidies from type 1 to insulin-requiring type 2 cohorts, a policy change that could lift sensor volumes by a further 20%.
High out-of-pocket cost of pump consumables outside insurance cover
While public and private schemes offset sensor costs, many Australians still pay USD 4,600-USD 6,600 equivalent for pump consumables across a four-year warranty cycle. Parliamentary modelling shows universal pump subsidies would require up to AUD 749 million over forward estimates. Price pressures deter uptake among low-income adults, contributing to slower penetration of automated insulin delivery systems beyond paediatric segments. The Australia diabetes devices market therefore faces a ceiling effect until funding parity with CGM is achieved.
Other drivers and restraints analyzed in the detailed report include:
Rapid uptake of digital health and telehealth services / Local R&D for non-invasive CGM / Limited interoperability between imported pumps & local apps /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Monitoring devices generated 57.13% of Australia diabetes devices market revenue in 2025 and represent the anchor segment. Strong NDSS backing vaulted CGM penetration, making sensors routine even in primary care. At USD 410 million, the monitoring slice of the Australia diabetes devices market size benefits from frequent sensor replacement that ensures recurring revenue. The early-2025 addition of Dexcom G7 and FreeStyle Libre 2 Plus reinforced competitive intensity, with both brands offering twelve-hour warm-up times and predictive alert algorithms that satisfy national clinical guidelines.
Management devices earned the remaining share but are expanding at a 3.10% CAGR, the fastest within the portfolio. Evidence from multi-centre Queensland trials indicates that automated insulin delivery improves time-in-range by 15 percentage points, translating to lower complication risk and stronger payer support. If the proposed universal pump subsidy passes Parliament by 2026, uptake could propel the therapy segment to USD 380 million by 2030, thereby shrinking the gap between monitoring and management categories within the Australia diabetes devices market.
Hospital systems contributed 48.31% of Australia diabetes devices market share in 2025 because they are the primary enrolment point for pump initiation, sensor training, and acute complication management. Large metropolitan teaching hospitals run specialised diabetes technology clinics that standardise device selection protocols. In rural regions, district hospitals rely on visiting nurse educators, yet still dominate procurement budgets, reinforcing hospital grip on the supply chain of the Australia diabetes devices market.
Home-care settings are climbing at a 3.00% CAGR as telehealth compresses geographic constraints. A national survey showed 64% of sensor users now transmit real-time glucose data to clinicians from home, reducing routine clinic visits. Private insurers are piloting bundled payment models that provide sensors, smart pens, and virtual coaching under a single premium. This shift encourages longer-term adherence, suggesting home-care could surpass 35% revenue share of the Australia diabetes devices market by 2030.
The Australia Diabetes Devices Market Report Segments the Industry Into Device Type (Management Devices and Monitoring Devices), by End User (Home-Care Settings, Hospitals, and More), by Diabetes Type (Type 1 Diabetes, Type 2 Diabetes and Gestational Diabetes), by Technology (Invasive Systems, Minimally Invasive Systems, and Non-Invasive Systems). The Market Sizes and Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Abbott Laboratories / Medtronic / Dexcom / Roche / Novo Nordisk / Sanofi / Eli Lilly and Company / Lifescan / Ascensia / Insulet / Ypsomed / Tandem Diabetes Care / Senseonics / B. Braun / Arkray / AgaMatrix / Terumo /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Expansion Of CGM Reimbursement Via NDSS & Private Health Funds
4.2.2 Escalating Diabetes Prevalence
4.2.3 Rapid Uptake Of Digital Health And Telehealth Services
4.2.4 Surge In Local R&D For Non-Invasive CGM
4.2.5 Accelerated Rollout Of Next-Generation Solutions
4.2.6 Corporate Wellness Programs Integrating Connected Glucose Sensors
4.3 Market Restraints
4.3.1 High Out-Of-Pocket Cost Of Pump Consumables Outside Insurance Cover
4.3.2 Workforce And Training Gaps
4.3.3 Limited Interoperability Between Imported Pumps & Local Apps
4.3.4 Stringent TGA Post-Market Surveillance Slowing New Launches
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Outlook (Therapeutic Goods Administration Focus)
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Bargaining Power of Suppliers
4.7.2 Bargaining Power of Consumers
4.7.3 Threat of New Entrants
4.7.4 Threat of Substitutes
4.7.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value & Volume)
5.1 By Device Type
5.1.1 Management Devices
5.1.1.1 Insulin Pumps
5.1.1.1.1 Pump Device
5.1.1.1.2 Reservoir
5.1.1.1.3 Infusion Set
5.1.1.2 Insulin Syringes
5.1.1.3 Cartridges in Re-usable Pens
5.1.1.4 Disposable Insulin Pens
5.1.1.5 Jet Injectors
5.1.2 Monitoring Devices
5.1.2.1 Self-Monitoring Blood Glucose
5.1.2.1.1 Glucometer Devices
5.1.2.1.2 Test Strips
5.1.2.1.3 Lancets
5.1.2.2 Continuous Glucose Monitoring
5.1.2.2.1 Sensors
5.1.2.2.2 Durables / Transmitters
5.1.2.3 Emerging Non-Invasive CGM Prototypes
5.2 By End User
5.2.1 Home-Care Settings
5.2.2 Hospitals
5.2.3 Specialty Diabetes Clinics
5.2.4 Community & Retail Pharmacies (Point-of-Care)
5.3 By Diabetes Type
5.3.1 Type 1 Diabetes
5.3.2 Type 2 Diabetes
5.3.3 Gestational Diabetes
5.4 By Technology
5.4.1 Invasive Systems
5.4.2 Minimally Invasive Systems
5.4.3 Non-Invasive Systems
6 Market Indicators
6.1 Type-1 Diabetes Population
6.2 Type-2 Diabetes Population
7 Competitive Landscape
7.1 Market Concentration
7.2 Market Share Analysis
7.3 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
7.3.1 Abbott Diabetes Care
7.3.2 Medtronic
7.3.3 Dexcom Inc.
7.3.4 Roche Diabetes Care
7.3.5 Novo Nordisk A/S
7.3.6 Sanofi
7.3.7 Eli Lilly and Company
7.3.8 LifeScan Inc.
7.3.9 Ascensia Diabetes Care
7.3.10 Insulet Corporation
7.3.11 Ypsomed Holding AG
7.3.12 Tandem Diabetes Care
7.3.13 Senseonics Holdings Inc.
7.3.14 B. Braun Melsungen AG
7.3.15 ARKRAY Inc.
7.3.16 AgaMatrix Inc.
7.3.17 Terumo Corporation
8 Market Opportunities & Future Outlook
8.1 White-Space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security